Bevacizumab biosimilar (Elea)
贝伐珠单抗生物类似药 (Elea)
Report date: 2022/03/14 16:56:43
Base Information
Drug NameBevacizumab biosimilar (Elea)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved Indications
Approved Indications in ChinaN/A
Original Approved Country/Territory
Original Approved Date2018/04/26
Country/Territory
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesLaboratorio Elea Phoenix Sa
China Registration ClassN/A
Develop Information
Active CompaniesLaboratorio Elea Phoenix Sa
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC Code
Related LinksN/A